Cargando…

High-Density Lipoproteins in Non-Cardiovascular Diseases

Detalles Bibliográficos
Autor principal:	Zanotti, Ilaria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9408873/ https://www.ncbi.nlm.nih.gov/pubmed/36012681 http://dx.doi.org/10.3390/ijms23169413

Ejemplares similares

High-Density Lipoproteins and Cardiovascular Disease: The Good, the Bad and the Future
por: Julve, Josep, et al.
Publicado: (2021)

High-Density Lipoproteins and Cardiovascular Disease: The Good, the Bad, and the Future
por: Julve, Josep, et al.
Publicado: (2021)

High-Density Lipoproteins and Cardiovascular Disease: The Good, the Bad, and the Future II
por: Julve, Josep, et al.
Publicado: (2022)

Is Non-High-Density Lipoprotein Cholesterol Evaluation Perfect? From the High-Density Lipoprotein Function Viewpoint
por: Otsuka, Toshiaki
Publicado: (2022)

Current Status of Low-Density Lipoprotein Cholesterol and Cardiovascular Diseases in Japan
por: Sun, Wanlu, et al.
Publicado: (2023)

Physical Fitness and Development of High Non-High-Density Lipoprotein Cholesterol
por: Koba, Shinji
Publicado: (2018)

Re‐examining the high‐density lipoprotein hypothesis
por: Tan, Kathryn
Publicado: (2016)

The Ratio of Triglyceride to High-density Lipoprotein Cholesterol as an Indicator of Risk Stratification for Atherosclerotic Cardiovascular Disease in a Clinical Setting
por: Tani, Shigemasa
Publicado: (2020)

High density lipoproteins-based therapies for cardiovascular disease
por: Gao, Xuan, et al.
Publicado: (2010)

Changes in high-density lipoprotein cholesterol with risk of Cardiovascular Disease among initially high-density lipoprotein-high participants
por: Kim, Hye Jun, et al.
Publicado: (2023)

Dysfunctional High-Density Lipoproteins in Type 2 Diabetes Mellitus: Molecular Mechanisms and Therapeutic Implications
por: Bonilha, Isabella, et al.
Publicado: (2021)

Age and Cardiovascular Risk Attributable to Apolipoprotein B, Low‐Density Lipoprotein Cholesterol or Non‐High‐Density Lipoprotein Cholesterol
por: Sniderman, Allan D., et al.
Publicado: (2016)

High-density lipoprotein: does it have a dark side?
por: Von Feldt, Joan M
Publicado: (2008)

Modulation of High-Density Lipoprotein Function via Cardiac Rehabilitation
por: Satomi-Kobayashi, Seimi, et al.
Publicado: (2018)

The Long and Winding Road: To the Proper Understanding of High-density Lipoprotein
por: Sung, Jidong
Publicado: (2020)

Current Therapies Focused on High-Density Lipoproteins Associated with Cardiovascular Disease
por: Estrada-Luna, Diego, et al.
Publicado: (2018)

Artificial High Density Lipoprotein Nanoparticles in Cardiovascular Research
por: Kornmueller, Karin, et al.
Publicado: (2019)

Anti-high-density lipoprotein antibodies and lipoprotein characteristics in systemic lupus erythematosus-related cardiovascular disease
por: Su, J, et al.
Publicado: (2005)

Difference in Serum Non-High-Density Lipoprotein Cholesterol Levels in terms of Sex, Age, and Physique in Children and Adolescents
por: Abe, Yuriko
Publicado: (2016)

Association of trajectories of non-high-density lipoprotein cholesterol concentration with risk of cardiovascular disease: the Kailuan Study
por: Ding, Xiong, et al.
Publicado: (2023)

Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
por: Chapman, M. John, et al.
Publicado: (2011)

Association between the Non-high-Density Lipoprotein Cholesterol to High-Density Lipoprotein Cholesterol Ratio and the Risk of Coronary Artery Disease
por: You, Jiayin, et al.
Publicado: (2020)

Induction of Autophagy: A Novel Anti-inflammatory Function of High-Density Lipoprotein
por: Reardon, Catherine A.
Publicado: (2015)

What is the Cause of Continuous and Marked Increase of Japanese High Density Lipoprotein Cholesterol?
por: Ueshima, Hirotsugu
Publicado: (2023)

Fish-Derived Omega-3 Fatty Acids: Guardians of High-Density Lipoprotein?
por: Toh, Ryuji
Publicado: (2023)

High density lipoprotein cholesterol: an evolving target of therapy in the management of cardiovascular disease
por: Kapur, Navin K, et al.
Publicado: (2008)

Molecular mechanisms of vascular effects of High-density lipoprotein: alterations in cardiovascular disease
por: Besler, Christian, et al.
Publicado: (2012)

High-density lipoprotein (HDL) functionality and its relevance to atherosclerotic cardiovascular disease
por: Kosmas, Constantine E, et al.
Publicado: (2018)

Precision Nutrition and Cardiovascular Disease Risk Reduction: the Promise of High-Density Lipoproteins
por: Hong, Brian V., et al.
Publicado: (2023)

High-density lipoproteins and non-alcoholic fatty liver disease
por: Hoekstra, Menno, et al.
Publicado: (2023)

Physiological Bases for the Superiority of Apolipoprotein B Over Low‐Density Lipoprotein Cholesterol and Non–High‐Density Lipoprotein Cholesterol as a Marker of Cardiovascular Risk
por: Glavinovic, Tamara, et al.
Publicado: (2022)

Cholesterol efflux promoting function of high-density lipoproteins in calcific aortic valve stenosis
por: Kocyigit, Duygu, et al.
Publicado: (2021)

High-Density Lipoproteins in Kidney Disease
por: Kon, Valentina, et al.
Publicado: (2021)

The Achievement of Non-high-density Lipoprotein Cholesterol Target in Patients with Very High Atherosclerotic Cardiovascular Disease Risk Stratified by Triglyceride Levels Despite Statin-controlled Low-density Lipoprotein Cholesterol
por: Al-Sabti, Hilal, et al.
Publicado: (2022)

Non-High-Density Lipoprotein Cholesterol and Risk of Cardiovascular Disease: The Japan Epidemiology Collaboration on Occupational Health Study
por: Hu, Huan, et al.
Publicado: (2022)

Residual Risk Still Remains in Low-Density Lipoprotein
por: Hirano, Tsutomu
Publicado: (2022)

Of statins and low-density lipoprotein cholesterol, “fats” and fiction
por: Unnikrishnan, Ambika Gopalakrishnan, et al.
Publicado: (2016)

High-Density Lipoprotein (HDL) Triglyceride and Oxidized HDL: New Lipid Biomarkers of Lipoprotein-Related Atherosclerotic Cardiovascular Disease
por: Ito, Fumiaki, et al.
Publicado: (2020)

High-density lipoprotein cholesterol (HDL-C) in cardiovascular disease: effect of exercise training
por: Ahn, Nayoung, et al.
Publicado: (2016)

Utility of Non-High-Density Lipoprotein Cholesterol to High-Density Lipoprotein Cholesterol Ratio in Evaluating Incident Diabetes Risk
por: Sheng, Guotai, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hbfqjj116vlh4uihgccbsjgaul